Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
For hepatic cirrhosis subjects with ascites or lower extremities, to study Pharmacokinetics,
pharmacology, and safety of the drug under fasting condition.